Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical)

v3.19.3
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical) - Convertible Notes Payable [Member]
9 Months Ended
Sep. 30, 2019
USD ($)
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Common stock issuable upon conversion | $ $ 805,000
Common stock issuable upon conversion, shares | shares 8,050,000
Beneficial ownership limitations percentage 4.99%